Internal Medicine, Gastroenterology · Louisville, KY
NPI
1700010675
Since 2009
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
550 S Jackson St, Acb Building, 3rd Floor
Louisville, KY, 40202
Phone (502) 852-1384
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
937 services
Medicare patients, 2024
369
Average age 69
Drug cost, 2024
$2.3M
988 prescriptions
Company payments, 2025
$423
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Endashaw M Omer was code 99232 (hospital e&m - subsequent), 156 times for 81 patients. In total Endashaw M Omer billed 937 services in 54 codes, and Medicare paid $84K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 156 | 81 | $58.62 | $9,145 |
| 43239 Upper GI Endoscopy | Facility | 106 | 101 | $51.77 | $5,488 |
| 99214 Office E&M - Established | Office | 101 | 74 | $81.39 | $8,220 |
| 99233 Hospital E&M - Subsequent | Facility | 92 | 48 | $88.61 | $8,152 |
| 99223 Hospital E&M - Initial | Facility | 83 | 78 | $128.54 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 46 | 46 | $72.29 | $3,325 |
| 45385 Colonoscopy - Lesion Removal | Facility | 42 | 41 | $182.69 | $7,673 |
| 43235 Upper GI Endoscopy | Facility | 35 | 33 | $73.85 | $2,585 |
| 99222 Hospital E&M - Initial | Facility | 32 | 31 | $95.74 | $3,064 |
| 43242 Upper GI Endoscopy | Facility | 22 | 22 | $186.18 | $4,096 |
| 43259 Upper GI Endoscopy | Facility | 20 | 19 | $157.76 | $3,155 |
| 43251 Upper GI Endoscopy | Facility | 20 | 20 | $83.82 | $1,676 |
| 99213 Office E&M - Established | Office | 15 | 13 | $55.94 | $839 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $12.35 | $173 |
| 45378 Lower GI Endoscopy - Other | Facility | 11 | 11 | $105.27 | $1,158 |
By year: 2022 $69K for 775 services; 2023 $79K for 895 services; 2024 $84K for 937 services.
Medicare prescription drug claims, 2024
In 2024, the drug Endashaw M Omer prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 211 prescriptions and refills. In total Endashaw M Omer wrote 988 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 211 | 211 | 203 | $4,369 |
| Omeprazole Generic | 125 | 247 | 44 | $1,298 |
| Lactated Ringers Ringer's Solution,lactated | 60 | 60 | Under 11 | $7,849 |
| Sodium Chloride 0.9 % Sodium Chloride | 54 | 54 | Under 11 | $1,514 |
| Pantoprazole Sodium Generic | 39 | 76 | 11 | $472 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 38 | 38 | Under 11 | $1,301 |
| Loperamide Loperamide Hcl | 33 | 34 | Under 11 | $820 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 25 | 25 | 23 | $433 |
| Gattex Teduglutide | 24 | 24 | Under 11 | $1.6M |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 20 | 20 | 20 | $341 |
| Metronidazole Generic | 20 | 20 | 19 | $77.63 |
| Zenpep Lipase/Protease/Amylase | 19 | 22 | Under 11 | $30K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 19 | 20 | Under 11 | $1,447 |
| Xifaxan Rifaximin | 17 | 17 | Under 11 | $51K |
| Buspirone Hcl Generic | 17 | 17 | Under 11 | $41.24 |
Brand drugs: 359 claims; generic drugs: 629 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Endashaw M Omer $423 ($423 in general payments such as food, travel and fees) from 5 companies. The largest payer was Enterra Medical, Inc. with $176.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.